ID   ASPH_MOUSE              Reviewed;         741 AA.
AC   Q8BSY0; Q6P8S1; Q9EPA6; Q9EQ64;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   07-APR-2021, entry version 157.
DE   RecName: Full=Aspartyl/asparaginyl beta-hydroxylase;
DE            EC=1.14.11.16 {ECO:0000269|PubMed:11773073};
DE   AltName: Full=Aspartate beta-hydroxylase;
DE            Short=ASP beta-hydroxylase;
DE   AltName: Full=Peptide-aspartate beta-dioxygenase;
GN   Name=Asph; Synonyms=Bah;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Heart muscle;
RX   PubMed=8530521; DOI=10.1074/jbc.270.51.30787;
RA   Jones L.R., Zhang L., Sanborn K., Jorgensen A.O., Kelley J.;
RT   "Purification, primary structure, and immunological characterization of the
RT   26-kDa calsequestrin binding protein (junctin) from cardiac junctional
RT   sarcoplasmic reticulum.";
RL   J. Biol. Chem. 270:30787-30796(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), ALTERNATIVE SPLICING, AND
RP   TISSUE SPECIFICITY.
RC   STRAIN=BALB/cJ; TISSUE=Liver;
RX   PubMed=10956665; DOI=10.1074/jbc.m006753200;
RA   Dinchuk J.E., Henderson N.L., Burn T.C., Huber R., Ho S.P., Link J.,
RA   O'Neil K.T., Focht R.J., Scully M.S., Hollis J.M., Hollis G.F.,
RA   Friedman P.A.;
RT   "Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved isoform
RT   of Asph missing the catalytic domain share exons with junctin.";
RL   J. Biol. Chem. 275:39543-39554(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=BALB/cJ; TISSUE=Heart;
RA   Hong C., Kim D.H.;
RT   "Mouse junctin-1 mRNA.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   DISRUPTION PHENOTYPE, FUNCTION, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=11773073; DOI=10.1074/jbc.m110389200;
RA   Dinchuk J.E., Focht R.J., Kelley J.A., Henderson N.L., Zolotarjova N.I.,
RA   Wynn R., Neff N.T., Link J., Huber R.M., Burn T.C., Rupar M.J.,
RA   Cunningham M.R., Selling B.H., Ma J., Stern A.A., Hollis G.F., Stein R.B.,
RA   Friedman P.A.;
RT   "Absence of post-translational aspartyl beta-hydroxylation of epidermal
RT   growth factor domains in mice leads to developmental defects and an
RT   increased incidence of intestinal neoplasia.";
RL   J. Biol. Chem. 277:12970-12977(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [9]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=22768324; DOI=10.1371/journal.pone.0039962;
RA   Boncompagni S., Thomas M., Lopez J.R., Allen P.D., Yuan Q., Kranias E.G.,
RA   Franzini-Armstrong C., Perez C.F.;
RT   "Triadin/junctin double null mouse reveals a differential role for triadin
RT   and junctin in anchoring CASQ to the jSR and regulating Ca(2+)
RT   homeostasis.";
RL   PLoS ONE 7:E39962-E39962(2012).
RN   [10]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=24768550; DOI=10.1016/j.ajhg.2014.04.002;
RA   Patel N., Khan A.O., Mansour A., Mohamed J.Y., Al-Assiri A., Haddad R.,
RA   Jia X., Xiong Y., Megarbane A., Traboulsi E.I., Alkuraya F.S.;
RT   "Mutations in ASPH cause facial dysmorphism, lens dislocation, anterior-
RT   segment abnormalities, and spontaneous filtering blebs, or Traboulsi
RT   syndrome.";
RL   Am. J. Hum. Genet. 94:755-759(2014).
CC   -!- FUNCTION: [Isoform 1]: specifically hydroxylates an Asp or Asn residue
CC       in certain epidermal growth factor-like (EGF) domains of a number of
CC       proteins. {ECO:0000269|PubMed:11773073}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + L-aspartyl-[protein] + O2 = 3-hydroxy-L-
CC         aspartyl-[protein] + CO2 + succinate; Xref=Rhea:RHEA:11508,
CC         Rhea:RHEA-COMP:9867, Rhea:RHEA-COMP:14951, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:16810, ChEBI:CHEBI:17427,
CC         ChEBI:CHEBI:29961, ChEBI:CHEBI:30031; EC=1.14.11.16;
CC         Evidence={ECO:0000269|PubMed:11773073};
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC         Evidence={ECO:0000250|UniProtKB:Q12797};
CC   -!- SUBUNIT: Monomer. Isoform 2 interacts with CASQ2.
CC       {ECO:0000250|UniProtKB:Q12797, ECO:0000250|UniProtKB:Q28056}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q28056}; Single-pass type II membrane protein
CC       {ECO:0000250|UniProtKB:Q28056}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Sarcoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:8530521}; Single-pass type II membrane protein
CC       {ECO:0000303|PubMed:8530521}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8BSY0-1; Sequence=Displayed;
CC       Name=2; Synonyms=Junctin;
CC         IsoId=Q8BSY0-2; Sequence=VSP_056792, VSP_056793, VSP_056794;
CC       Name=3;
CC         IsoId=Q8BSY0-3; Sequence=VSP_060973, VSP_060974, VSP_060975;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is detected in heart, liver and ovary (at
CC       protein level). Detected in heart ventricle. Isoform 1 is widely
CC       expressed. Isoform 2 is detected in heart and skeletal muscle.
CC       {ECO:0000269|PubMed:10956665, ECO:0000269|PubMed:11773073,
CC       ECO:0000269|PubMed:8530521}.
CC   -!- DEVELOPMENTAL STAGE: Strongly expressed in the snout, limbs and eye of
CC       11.5 dpc and 12 dpc. Strong localization of the protein in the lens of
CC       the developing eye at all three stages. {ECO:0000269|PubMed:24768550}.
CC   -!- DISRUPTION PHENOTYPE: Selective disruption of isoform 1 abolishes liver
CC       aspartyl beta-hydroxylase activity, but does not affect the expression
CC       of isoform 2. Mice lacking isoform 1 have normal blood chemistry, do
CC       not present blood coagulation defects and appear more or less normal,
CC       except for shorter snouts, mild defects of the palate ridges,
CC       syndactily due to fusion of soft tissues and reduced litter size from
CC       mutant females, while male fertility appears normal. Mice lacking
CC       isoform 2 show no visible phenotype. {ECO:0000269|PubMed:11773073,
CC       ECO:0000269|PubMed:22768324}.
CC   -!- SIMILARITY: Belongs to the aspartyl/asparaginyl beta-hydroxylase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF221854; AAK00614.1; -; mRNA.
DR   EMBL; AF289486; AAG40808.1; -; mRNA.
DR   EMBL; AF289487; AAG40809.1; -; mRNA.
DR   EMBL; AF289490; AAG40812.1; -; mRNA.
DR   EMBL; AF223413; AAN87549.1; -; mRNA.
DR   EMBL; AK030293; BAC26882.1; -; mRNA.
DR   EMBL; AL671970; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL732508; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL773548; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC061098; AAH61098.1; -; mRNA.
DR   EMBL; BC128299; AAI28300.1; -; mRNA.
DR   EMBL; BC152365; AAI52366.1; -; mRNA.
DR   CCDS; CCDS17959.1; -. [Q8BSY0-2]
DR   CCDS; CCDS38690.1; -. [Q8BSY0-1]
DR   RefSeq; NP_001171321.1; NM_001177850.1.
DR   RefSeq; NP_001171323.1; NM_001177852.1.
DR   RefSeq; NP_001171324.1; NM_001177853.1.
DR   RefSeq; NP_001171325.1; NM_001177854.1.
DR   RefSeq; NP_001171326.1; NM_001177855.1.
DR   RefSeq; NP_001277296.1; NM_001290367.1.
DR   RefSeq; NP_075553.2; NM_023066.3. [Q8BSY0-1]
DR   SMR; Q8BSY0; -.
DR   BioGRID; 211167; 8.
DR   IntAct; Q8BSY0; 9.
DR   MINT; Q8BSY0; -.
DR   STRING; 10090.ENSMUSP00000077273; -.
DR   GlyConnect; 2136; 6 N-Linked glycans (2 sites).
DR   GlyGen; Q8BSY0; 2 sites.
DR   iPTMnet; Q8BSY0; -.
DR   PhosphoSitePlus; Q8BSY0; -.
DR   SwissPalm; Q8BSY0; -.
DR   EPD; Q8BSY0; -.
DR   jPOST; Q8BSY0; -.
DR   MaxQB; Q8BSY0; -.
DR   PaxDb; Q8BSY0; -.
DR   PRIDE; Q8BSY0; -.
DR   ProteomicsDB; 283188; -. [Q8BSY0-1]
DR   ProteomicsDB; 283189; -. [Q8BSY0-2]
DR   Antibodypedia; 24707; 312 antibodies.
DR   DNASU; 65973; -.
DR   Ensembl; ENSMUST00000078139; ENSMUSP00000077273; ENSMUSG00000028207. [Q8BSY0-1]
DR   GeneID; 65973; -.
DR   KEGG; mmu:65973; -.
DR   UCSC; uc008ryf.2; mouse. [Q8BSY0-1]
DR   CTD; 444; -.
DR   MGI; MGI:1914186; Asph.
DR   eggNOG; KOG3696; Eukaryota.
DR   GeneTree; ENSGT00940000156304; -.
DR   HOGENOM; CLU_106984_2_0_1; -.
DR   InParanoid; Q8BSY0; -.
DR   OrthoDB; 1324479at2759; -.
DR   PhylomeDB; Q8BSY0; -.
DR   TreeFam; TF312799; -.
DR   Reactome; R-MMU-2672351; Stimuli-sensing channels.
DR   Reactome; R-MMU-5578775; Ion homeostasis.
DR   BioGRID-ORCS; 65973; 1 hit in 52 CRISPR screens.
DR   ChiTaRS; Asph; mouse.
DR   PRO; PR:Q8BSY0; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; Q8BSY0; protein.
DR   Bgee; ENSMUSG00000028207; Expressed in quadriceps femoris and 295 other tissues.
DR   ExpressionAtlas; Q8BSY0; baseline and differential.
DR   Genevisible; Q8BSY0; MM.
DR   GO; GO:0032541; C:cortical endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; ISO:MGI.
DR   GO; GO:0016021; C:integral component of membrane; ISS:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; ISO:MGI.
DR   GO; GO:0004597; F:peptide-aspartate beta-dioxygenase activity; ISS:MGI.
DR   GO; GO:0062101; F:peptidyl-aspartic acid 3-dioxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0097202; P:activation of cysteine-type endopeptidase activity; ISO:MGI.
DR   GO; GO:0032237; P:activation of store-operated calcium channel activity; ISO:MGI.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISO:MGI.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISO:MGI.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISO:MGI.
DR   GO; GO:0060325; P:face morphogenesis; IMP:MGI.
DR   GO; GO:0035108; P:limb morphogenesis; IMP:MGI.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IGI:MGI.
DR   GO; GO:0007389; P:pattern specification process; IMP:MGI.
DR   GO; GO:0042264; P:peptidyl-aspartic acid hydroxylation; IDA:MGI.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; ISO:MGI.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; ISO:MGI.
DR   GO; GO:0045862; P:positive regulation of proteolysis; ISO:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISO:MGI.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; ISO:MGI.
DR   GO; GO:0031585; P:regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; ISO:MGI.
DR   GO; GO:1901879; P:regulation of protein depolymerization; IDA:BHF-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IDA:BHF-UCL.
DR   GO; GO:0033198; P:response to ATP; ISO:MGI.
DR   GO; GO:0060021; P:roof of mouth development; IMP:MGI.
DR   Gene3D; 1.25.40.10; -; 2.
DR   Gene3D; 2.60.120.330; -; 1.
DR   InterPro; IPR007943; Asp-B-hydro/Triadin_dom.
DR   InterPro; IPR007803; Asp/Arg/Pro-Hydrxlase.
DR   InterPro; IPR039038; ASPH.
DR   InterPro; IPR027443; IPNS-like.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   PANTHER; PTHR12366; PTHR12366; 1.
DR   Pfam; PF05279; Asp-B-Hydro_N; 1.
DR   Pfam; PF05118; Asp_Arg_Hydrox; 1.
DR   SMART; SM00028; TPR; 2.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   PROSITE; PS50005; TPR; 2.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Dioxygenase; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Iron; Membrane; Metal-binding;
KW   Oxidoreductase; Phosphoprotein; Reference proteome; Repeat;
KW   Sarcoplasmic reticulum; Signal-anchor; TPR repeat; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..741
FT                   /note="Aspartyl/asparaginyl beta-hydroxylase"
FT                   /id="PRO_0000254161"
FT   TOPO_DOM        1..62
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        63..83
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        84..741
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   REPEAT          324..357
FT                   /note="TPR 1"
FT   REPEAT          365..398
FT                   /note="TPR 2"
FT   REPEAT          437..470
FT                   /note="TPR 3"
FT   REPEAT          472..504
FT                   /note="TPR 4"
FT   REPEAT          508..540
FT                   /note="TPR 5"
FT   CA_BIND         99..111
FT                   /evidence="ECO:0000250|UniProtKB:Q12797"
FT   REGION          671..673
FT                   /note="2-oxoglutarate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q12797"
FT   COMPBIAS        9..61
FT                   /note="Gly-rich"
FT   COMPBIAS        14..38
FT                   /note="Ser-rich"
FT   COMPBIAS        310..315
FT                   /note="Poly-Lys"
FT   METAL           662
FT                   /note="Iron"
FT                   /evidence="ECO:0000250|UniProtKB:Q12797"
FT   METAL           708
FT                   /note="Iron"
FT                   /evidence="ECO:0000250|UniProtKB:Q12797"
FT   BINDING         608
FT                   /note="2-oxoglutarate"
FT                   /evidence="ECO:0000250|UniProtKB:Q12797"
FT   BINDING         651
FT                   /note="2-oxoglutarate"
FT                   /evidence="ECO:0000250|UniProtKB:Q12797"
FT   BINDING         718
FT                   /note="2-oxoglutarate"
FT                   /evidence="ECO:0000250|UniProtKB:Q12797"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12797"
FT   CARBOHYD        453
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        689
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        624..631
FT                   /evidence="ECO:0000250|UniProtKB:Q12797"
FT   VAR_SEQ         1..43
FT                   /note="MAPRKNAKGGGGNSSSSGSGSGSGSGSPSTGSSGSSSSPGARR -> MAEDK
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_056792"
FT   VAR_SEQ         93
FT                   /note="L -> LAKAKDFRYNLSEVLQ (in isoform 3)"
FT                   /id="VSP_060973"
FT   VAR_SEQ         117..245
FT                   /note="GLKERSPSERTFPPEEEAETHAELEEQAPEGADIQNVEDEVKEQIQSLLQES
FT                   VHTDHDLEADGLAGEPQPEVEDFLTVTDSDDRFEDLEPGTVHEEIEDTYHVEDTASQNH
FT                   PNDMEEMTNEQENSDPSE -> EGPGGLAKRKTKAKAKEPIKEELKKERGKAVPSKNEE
FT                   RRQGKKEQEDRGKGRKKPDSDTSQKASAAGKRDRDKEKASSDKSSKSKESWKKAVETKA
FT                   VSSKVAARDKDRRGRSSSGHAHVSKENGQKRKN (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_056793"
FT   VAR_SEQ         119..197
FT                   /note="KERSPSERTFPPEEEAETHAELEEQAPEGADIQNVEDEVKEQIQSLLQESVH
FT                   TDHDLEADGLAGEPQPEVEDFLTVTDS -> TKDGSNENIDSLEEVLTILAEESSDWFY
FT                   GFLSFLYDIMTPFEMLEEEEEESETADGVDGTSQNEGVQGKTCVILDLHNQ (in
FT                   isoform 3)"
FT                   /id="VSP_060974"
FT   VAR_SEQ         198..741
FT                   /note="Missing (in isoform 3)"
FT                   /id="VSP_060975"
FT   VAR_SEQ         246..741
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_056794"
FT   CONFLICT        131..132
FT                   /note="Missing (in Ref. 2; AAG40808/AAG40809)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        279
FT                   /note="A -> E (in Ref. 2; AAG40808/AAG40809)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   741 AA;  83042 MW;  0660A6A5E34418C8 CRC64;
     MAPRKNAKGG GGNSSSSGSG SGSGSGSPST GSSGSSSSPG ARREAKHGGH KNGRRGGISG
     GSFFTWFMVI ALLGVWTSVA VVWFDLVDYE EVLGKLGVYD ADGDGDFDVD DAKVLLGLKE
     RSPSERTFPP EEEAETHAEL EEQAPEGADI QNVEDEVKEQ IQSLLQESVH TDHDLEADGL
     AGEPQPEVED FLTVTDSDDR FEDLEPGTVH EEIEDTYHVE DTASQNHPND MEEMTNEQEN
     SDPSEAVTDA GVLLPHAEEV RHQDYDEPVY EPSEHEGVAI SDNTIDDSSI ISEEINVASV
     EEQQDTPPVK KKKPKLLNKF DKTIKAELDA AEKLRKRGKI EEAVNAFEEL VRKYPQSPRA
     RYGKAQCEDD LAEKQRSNEV LRRAIETYQE AADLPDAPTD LVKLSLKRRS ERQQFLGHMR
     GSLLTLQRLV QLFPSDTTLK NDLGVGYLLL GDNDSAKKVY EEVLNVTPND GFAKVHYGFI
     LKAQNKISES IPYLKEGIES GDPGTDDGRF YFHLGDAMQR VGNKEAYKWY ELGHKRGHFA
     SVWQRSLYNV NGLKAQPWWT PRETGYTELV KSLERNWKLI RDEGLMVMDK AKGLFLPEDE
     NLREKGDWSQ FTLWQQGRKN ENACKGAPKT CALLEKFSET TGCRRGQIKY SIMHPGTHVW
     PHTGPTNCRL RMHLGLVIPK EGCKIRCANE TRTWEEGKVL IFDDSFEHEV WQDASSFRLI
     FIVDVWHPEL TPQQRRSLPA I
//
